https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / J. Immunother. 2009 May;32(4):333-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / J. Immunother. 2009 May;32(4):333-402009-05-01 00:00:002019-02-15 08:48:40Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-22 / Blood 2009 Jan;113(1):18-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-22 / Blood 2009 Jan;113(1):18-272008-09-22 00:00:002019-02-15 09:25:29Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-01 / Clin Transl Oncol 2008 Sep;10(9):543-51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-01 / Clin Transl Oncol 2008 Sep;10(9):543-512008-09-01 00:00:002019-02-15 09:25:30Therapeutic vaccines for non-Hodgkin B-cell lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-01 / Bull Cancer 2008 Mar;95(3):320-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-01 / Bull Cancer 2008 Mar;95(3):320-62008-03-01 00:00:002019-02-15 08:51:24Immunotherapy of hematological malignancies using dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Am. J. Hematol. 2008 Feb;83(2):144-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Am. J. Hematol. 2008 Feb;83(2):144-92008-02-01 00:00:002019-02-15 09:25:31Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-09 / Blood 2008 Feb;111(3):1504-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-09 / Blood 2008 Feb;111(3):1504-112007-11-09 00:00:002019-02-15 09:25:30Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-25 / J Transl Med 2007 Sep;5:46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-25 / J Transl Med 2007 Sep;5:462007-09-25 00:00:002019-02-15 09:25:32Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-15 / Cancer Res. 2007 Sep;67(18):8450-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-15 / Cancer Res. 2007 Sep;67(18):8450-52007-09-15 00:00:002019-02-15 09:25:34Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / J. Vet. Med. Sci. 2007 Sep;69(9):925-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / J. Vet. Med. Sci. 2007 Sep;69(9):925-302007-09-01 00:00:002019-02-15 09:25:33Comparison of dendritic cell-mediated immune responses among canine malignant cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-30 / Physiol Res 2008;57(2):289-98
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-30 / Physiol Res 2008;57(2):289-982007-05-30 00:00:002007-05-30 00:00:00Dendritic cells and T lymphocyte interactions in patients with lymphoid malignancies
